Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Pharmacokinetics of Olorofim in Healthy Japanese and Caucasian Adults
jRCT2031230016Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of olorofim in mycoses, sponsored by Shionogi & Co., Ltd. Primary endpoints: Cmax of olorofim and AUC0-last of olorofim. Started Mar 2023; status: completed.
02
Drugs
olorofim
03
Conditions
mycoses
Beyond the preview
Go deeper on jRCT2031230016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230016.